Agilon Health (AGL) Invested Capital (2020 - 2026)

Agilon Health (AGL) has reported Invested Capital for 7 consecutive years, with $277.7 million the latest figure, recorded in Q1 2026.

• Invested Capital for Q1 2026 came in at $277.7 million, down 56.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $277.7 million (down 56.04% YoY), and the FY2025 annual result was $258.3 million, down 51.82% from the prior year.
• Invested Capital was $277.7 million for Q1 2026 at Agilon Health, up from $258.3 million in the prior quarter.
• Over five years, Invested Capital peaked at $1.1 billion in Q1 2022 and troughed at $258.3 million in Q4 2025.
• Average Invested Capital over 5 years is $735.6 million, with a median of $699.5 million recorded in 2023.
• Year-over-year, Invested Capital soared 474.35% in 2022 and tumbled 56.04% in 2026.
• Over 5 years, Invested Capital stood at $1.0 billion in 2022, then sank by 33.1% to $699.5 million in 2023, then dropped by 23.35% to $536.2 million in 2024, then slumped by 51.82% to $258.3 million in 2025, then rose by 7.51% to $277.7 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $277.7 million in Q1 2026, $258.3 million in Q4 2025, and $341.1 million in Q3 2025.